The UKMi Medicines Q&As published on this website are produced for NHS healthcare professionals by UK Medicines Information (UKMi) pharmacists in response to a demand to make available high quality, evidence-based, and quality controlled answers to common or unusual enquiries made to Medicines Information services. These Q&As may provide either a complete answer, or a starting point for additional tailoring, to a specific related enquiry. The Q&As have a nominal review date of 2 years after writing, but may be updated sooner if new information and evidence warrants an interim change. The number of Q&As in the programme is under continuous review, with new topics added as the need is identified.
You can search for a UKMi Medicines Q&A from the homepage using a relevant keyword or keywords (e.g. drug name) in the search box. Alternatively you can click on the link to ‘Medicines Articles’ from the homepage, and use the filter ‘Q&A’ for a list of all Q&As on the website. However please be aware that not all Q&As on the website are UKMi Medicines Q&As, so the results generated will include other types of Q&As produced by different organisations.
Any queries related to UKMi Medicines Q&As should be referred to the individual author or their place of work (details provided at the end of each Q&A).
New and updated UKMi Medicines Q&As will be highlighted in the ‘Q&A’ section on the homepage of this website (next to ‘News’), as well as via the NICE Evidence Medicines Awareness updates to registered users (click here to register).
Disclaimer for use of UKMi Medicines Q&As
- This document has been prepared by UK Medicines Information (UKMi) pharmacists for the National Health Service (NHS), and contains an answer, or provides a starting point (or ‘signpost’) for additional tailoring, to a specific question about medicines use.
- The UKMi Medicines Q&A documents are intended for use by NHS healthcare professionals and cannot be used for commercial or marketing purposes.
- Members of the public or professionals from outside the UK may need assistance to interpret the information and to translate it to their own situation. It is strongly recommended to seek relevant professional help in such cases.
- The question and answer (Q&A) relates solely to the clinical scenario described within the text. You are strongly advised to read the entire document, and in particular to take into account any limitations highlighted. Should you have any doubts about whether the scenario is relevant to a specific patient, or be unsure whether you understand the answer, it is again recommended that you seek professional assistance.
- UKMi Medicines Q&As are believed to be an accurate reflection of the medical literature at the time of preparation. However, users should always consult the literature and take account of new developments because these may change an answer.
- Where authors have given their contact details at the bottom of the Q&A, this indicates that he or she may be willing to assist with any further enquiries related to the subject. However, enquirers should bear in mind that authors are NHS employees concerned with the care of patients in their employing organisation and may not be able to respond quickly.
- The authors of UKMi Medicines Q&As are not responsible for the content of external websites and links are made available solely to indicate their potential usefulness. You must use your judgement to determine the accuracy and relevance of the information they contain.
- Using this UKMi Medicines Q&A indicates that you have read, understood and accepted the above.
Principal Pharmacist Critical Evaluation and UKMi Medicines Q&A Lead, Southampton Medicines Advice Service, University Hospital of Southampton NHS Foundation Trust